Pi kur, 2004
... speciation in yeasts. Nature 422: 68–72. Frazer, K.A., et al. (2003) Cross-species sequence comparisons: a review of methods and available resources.Genome Res 13: ...
... speciation in yeasts. Nature 422: 68–72. Frazer, K.A., et al. (2003) Cross-species sequence comparisons: a review of methods and available resources.Genome Res 13: ...
Leukaemia Section t(3;18)(q26;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology
... Only one case to date, a 73 year old female patient. ...
... Only one case to date, a 73 year old female patient. ...
RUNX1-RUNX1T1 pre
... (1), amplification of cDNA of the TBP gene from Kasumi-1 cells (2), amplification of cDNA of the RBFOX3 gene from normal PBMNC (3, 5), BMMNC (7, 9), CD34+HPSC(11, 13) and from Kasumi-1 cells (15) and amplification of cDNA of the RBFOX3 gene from respective RT−negative controls (4, 6, 8, 10, 12, 14, ...
... (1), amplification of cDNA of the TBP gene from Kasumi-1 cells (2), amplification of cDNA of the RBFOX3 gene from normal PBMNC (3, 5), BMMNC (7, 9), CD34+HPSC(11, 13) and from Kasumi-1 cells (15) and amplification of cDNA of the RBFOX3 gene from respective RT−negative controls (4, 6, 8, 10, 12, 14, ...
the velocardiofacial syndrome
... plastic. Epileptic seizures occur in 80% of the patients with an onset varying between one month and 5 years. A diversity of seizures can be observed, ranging from atypical absence seizures, tonic-clonic seizures, myoclonic seizures, and tonic seizures to status epilepticus. They are difficult to co ...
... plastic. Epileptic seizures occur in 80% of the patients with an onset varying between one month and 5 years. A diversity of seizures can be observed, ranging from atypical absence seizures, tonic-clonic seizures, myoclonic seizures, and tonic seizures to status epilepticus. They are difficult to co ...
The Radiobiology of Radiation Therapy
... either replacement or repopulation of the cells killed Usually there is days to weeks delay before this begins Tissues with large clonogenic populations are able to do this better ...
... either replacement or repopulation of the cells killed Usually there is days to weeks delay before this begins Tissues with large clonogenic populations are able to do this better ...
Slide 2
... provided by the other parent. This process of reduction of the genetic information during the formation of the gametes is called meiosis. In this process, one diploid cell gives origin to 4 haploid cells. Prior to the meiotic division, during a period called “Interphase”, the chromosomes are compose ...
... provided by the other parent. This process of reduction of the genetic information during the formation of the gametes is called meiosis. In this process, one diploid cell gives origin to 4 haploid cells. Prior to the meiotic division, during a period called “Interphase”, the chromosomes are compose ...
Breeding desired quality wheat by reverse genetics
... test (SKCS) showed phenotypes with harder or softer grain character were identified in these mutants. A recent survey by Pickering and Bhave (2007) of the genotypes of Australian hard wheats noted the presence of only the Pina-D1b and Pinb-D1b types. The TILLING work allows for the expansion of the ...
... test (SKCS) showed phenotypes with harder or softer grain character were identified in these mutants. A recent survey by Pickering and Bhave (2007) of the genotypes of Australian hard wheats noted the presence of only the Pina-D1b and Pinb-D1b types. The TILLING work allows for the expansion of the ...
Gene Set Testing - USU Math/Stat
... a replicate experiment would measure new genes on the same subjects does not mimic actual biological experiment strongly discouraged ...
... a replicate experiment would measure new genes on the same subjects does not mimic actual biological experiment strongly discouraged ...
cancer/testis antigens, gametogenesis and cancer
... transcriptional data do not establish the genes as encoding tumour antigens, for consistency and in recognition of the origin of this field, the products of all genes identified as having cancer and germline expression are now referred to as CT antigens. The present catalogue of CT antigens4 contain ...
... transcriptional data do not establish the genes as encoding tumour antigens, for consistency and in recognition of the origin of this field, the products of all genes identified as having cancer and germline expression are now referred to as CT antigens. The present catalogue of CT antigens4 contain ...
GUS_Web_Applications
... Allgenes is based on a comprehensive mouse and human gene index. The genes are approximated by transcripts predicted from EST and mRNA clustering ...
... Allgenes is based on a comprehensive mouse and human gene index. The genes are approximated by transcripts predicted from EST and mRNA clustering ...
Studying Genomes
... Full genome sequencing Full genome sequencing involves sequencing not only nuclear DNA, but also the DNA contained within mitochondria and chloroplasts. With this vast quantity of information, comparisons can be made between individuals of the same species and between different species. This gives ...
... Full genome sequencing Full genome sequencing involves sequencing not only nuclear DNA, but also the DNA contained within mitochondria and chloroplasts. With this vast quantity of information, comparisons can be made between individuals of the same species and between different species. This gives ...
Chloroplast genes for components of the ATP synthase complex
... petition of the immunoprecipitation by added unlabelled authentic material. By this means, the positions of genes for subunits a, p, E and I11 have been located in wheat (Fig. la), and a,fi and I11 in pea (Fig. 1b). In addition, the positions of genes for subunit a in wheat, and a, p, E and I11 in p ...
... petition of the immunoprecipitation by added unlabelled authentic material. By this means, the positions of genes for subunits a, p, E and I11 have been located in wheat (Fig. la), and a,fi and I11 in pea (Fig. 1b). In addition, the positions of genes for subunit a in wheat, and a, p, E and I11 in p ...
Severe axonal Charcot-Marie-Tooth disease with proximal
... Photographs of the patient are shown in Fig. 1. Nerve conduction studies results are summarized in Table 2. The patient has been tested, since 2001, for PMP22 duplication/deletion and Sanger sequencing of MPZ, MFN2 and GDAP1 genes were performed. In 2014 we targeted parallel sequencing with a gene p ...
... Photographs of the patient are shown in Fig. 1. Nerve conduction studies results are summarized in Table 2. The patient has been tested, since 2001, for PMP22 duplication/deletion and Sanger sequencing of MPZ, MFN2 and GDAP1 genes were performed. In 2014 we targeted parallel sequencing with a gene p ...
In recent times the incidence of multiple drug resistant pathogens
... In addition to the gene of interest the expression cassette also carries a number of other regulatory sequences such as control elements (promoter/enhancer) necessary for expression of the genes i.e. to produce the protein it codes for. It also contains a selectable marker gene such as an antibiotic ...
... In addition to the gene of interest the expression cassette also carries a number of other regulatory sequences such as control elements (promoter/enhancer) necessary for expression of the genes i.e. to produce the protein it codes for. It also contains a selectable marker gene such as an antibiotic ...
Cellcycle-Worksheet_MH
... a. The human gene EGFR located on chromosome 7 is a proto-oncogene that codes for a growth factor cell surface receptor. The binding of growth factors to this receptor can lead to cell proliferation. Hypothesize what potential impact a mutated EGFR allele will have on a cell. Give one possible impa ...
... a. The human gene EGFR located on chromosome 7 is a proto-oncogene that codes for a growth factor cell surface receptor. The binding of growth factors to this receptor can lead to cell proliferation. Hypothesize what potential impact a mutated EGFR allele will have on a cell. Give one possible impa ...
Cloning and expression of chromosomally and plasmid
... [1]. Except for its key enzymes nbulose-l,5-blsphosphate carhoxylase/oxygenase (RuBisCO) and phosphonbulohnase (PRK) the cycle comprises enzymes catalyzing reactions also involved m heterotropbac carbon metabohsm. Among these enzymes are fructose-l,6-/sedoheptulose-l,7-b~sphosphatase (FSBP) and glyc ...
... [1]. Except for its key enzymes nbulose-l,5-blsphosphate carhoxylase/oxygenase (RuBisCO) and phosphonbulohnase (PRK) the cycle comprises enzymes catalyzing reactions also involved m heterotropbac carbon metabohsm. Among these enzymes are fructose-l,6-/sedoheptulose-l,7-b~sphosphatase (FSBP) and glyc ...
AP Bio Ch.18 “Genetics of Viruses and Bacteria” The Genetics of Viruses
... When you don’t want whole genome, just mRNA or protein. ...
... When you don’t want whole genome, just mRNA or protein. ...
Human male sex determination and sexual differentiation
... genes. SOX9, another SRY-related HMG-box containing gene, is a typical transcription factor with discrete DNA binding and transcriptional trans-activation domains. SOX9 is composed of the HMG domain, a proline, glutamine and alanine (PQA) domain and a proline, glutamine and serine-rich domain (PQS). ...
... genes. SOX9, another SRY-related HMG-box containing gene, is a typical transcription factor with discrete DNA binding and transcriptional trans-activation domains. SOX9 is composed of the HMG domain, a proline, glutamine and alanine (PQA) domain and a proline, glutamine and serine-rich domain (PQS). ...
gal
... copy of itself to another locus on the same or a different chromosome (hopping DNA), …may be a single insertion sequence, or a more complex structure (transposon) consisting of two insertion sequences and one or more intervening genes. ...
... copy of itself to another locus on the same or a different chromosome (hopping DNA), …may be a single insertion sequence, or a more complex structure (transposon) consisting of two insertion sequences and one or more intervening genes. ...
Transcription, chromatin condensation, and gene
... moved independently of each other. This argues against attachment of the transcriptional machinery to a stable nuclear scaffold (Jackson et al., 1984), at least one that extends over a large area of the nucleus. The current observations, however, could be explained by either a more dynamic or a more ...
... moved independently of each other. This argues against attachment of the transcriptional machinery to a stable nuclear scaffold (Jackson et al., 1984), at least one that extends over a large area of the nucleus. The current observations, however, could be explained by either a more dynamic or a more ...
Causes, Risks, Prevention
... people with AML don’t have risk factors that can be changed, at the present time there is no known way to prevent most cases of AML. Smoking is by far the most significant controllable risk factor for AML, and quitting offers the greatest chance to reduce a person’s risk of AML. Of course, non-smoke ...
... people with AML don’t have risk factors that can be changed, at the present time there is no known way to prevent most cases of AML. Smoking is by far the most significant controllable risk factor for AML, and quitting offers the greatest chance to reduce a person’s risk of AML. Of course, non-smoke ...
Oncogenomics
Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. Oncogenomics is synonymous with ""cancer genomics"". Cancer is a genetic disease caused by accumulation of mutations to DNA leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers, and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin, and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment.Besides understanding the underlying genetic mechanisms that initiates or drives cancer progression, one of the main goals of oncogenomics is to allow for the development of personalized cancer treatment. Cancer develops due to an accumulation of mutations in DNA. These mutations accumulate randomly, and thus, different DNA mutations and mutation combinations exist between different individuals with the same type of cancer. Thus, identifying and targeting specific mutations which have occurred in an individual patient may lead to increased efficacy of cancer therapy.The completion of the Human Genome Project has greatly facilitated the field of oncogenomics and has increased the abilities of researchers to find cancer causing genes. In addition, the sequencing technologies now available for sequence generation and data analysis have been applied to the study of oncogenomics. With the amount of research conducted on cancer genomes and the accumulation of databases documenting the mutational changes, it has been predicted that the most important cancer-causing mutations, rearrangements, and altered expression levels will be cataloged and well characterized within the next decade.Cancer research may look either on the genomic level at DNA mutations, the epigenetic level at methylation or histone modification changes, the transcription level at altered levels of gene expression, or the protein level at altered levels of protein abundance and function in cancer cells. Oncogenomics focuses on the genomic, epigenomic, and transcript level alterations in cancer.